These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 4547248)

  • 1. Lysis of human erythrocytes due to activation of the alternate complement pathway by nephritic factor (C3NeF).
    Arroyave CM; Vallota EH; Müller-Eberhard HJ
    J Immunol; 1974 Sep; 113(3):764-8. PubMed ID: 4547248
    [No Abstract]   [Full Text] [Related]  

  • 2. A serum factor in chronic hypocomplementemic hephritis distinct from immunoglobulins and activating the alternate pathway of complement.
    Vallota EH; Götze O; Spiegelberg HL; Forristal J; West CD; Müller-Eberhard HJ
    J Exp Med; 1974 May; 139(5):1249-61. PubMed ID: 4207623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paroxysmal nocturnal hemoglobinuria. Hemolysis initiated by the C3 activator system.
    Götze O; Müller-Eberhard HJ
    N Engl J Med; 1972 Jan; 286(4):180-4. PubMed ID: 5007123
    [No Abstract]   [Full Text] [Related]  

  • 4. A functional abnormality of the fifth component of complement (C5) from human serum of individuals with a familial opsonic defect.
    Nilsson UR; Miller ME; Wyman S
    J Immunol; 1974 Mar; 112(3):1164-76. PubMed ID: 4204560
    [No Abstract]   [Full Text] [Related]  

  • 5. Paroxysmal nocturnal hemoglobinuria. Alternate-complement-pathway-mediated lysis induced by magnesium.
    May JE; Rosse W; Frank MM
    N Engl J Med; 1973 Oct; 289(14):705-9. PubMed ID: 4727529
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum factors activating the alternative complement pathway in autoimmune disease: description of two different factors from patients with systemic lupus erythematosus.
    Arroyave CM; Wilson MR; Tan EM
    J Immunol; 1976 Mar; 116(3):821-6. PubMed ID: 815434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [ Complement activation by the alternate pathway (or properdin pathway) in paroxysmal nocturnal hemoglobinuria].
    Audran R
    Rev Fr Transfus; 1974 Dec; 17(4):333-48. PubMed ID: 4464553
    [No Abstract]   [Full Text] [Related]  

  • 8. Deviated lysis: transfer of complement lytic activity to unsensitized cells. IV. Parital isolation of the activity.
    Hänsch G; Rother U; Rother K
    Z Immunitatsforsch Immunobiol; 1977 Apr; 153(1):48-59. PubMed ID: 868206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement lysis of human erythrocytes. III. Differing effectiveness of human and guinea pig C9 on normal and paroxysmal nocturnal hemoglobinuria cells.
    Rosenfeld SI; Packman CH; Jenkins DE; Countryman JK; Leddy JP
    J Immunol; 1980 Nov; 125(5):2063-8. PubMed ID: 6776186
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunopathology of the renal complications of babesiosis.
    Annable CR; Ward PA
    J Immunol; 1974 Jan; 112(1):1-8. PubMed ID: 4272920
    [No Abstract]   [Full Text] [Related]  

  • 11. Complement lysis of human erythrocytes. II. A unique interaction of human C8 and C9 with paroxysmal nocturnal hemoglobinuria erythrocytes.
    Packman CH; Rosenfeld SI; Jenkins DE; Leddy JP
    J Immunol; 1980 Jun; 124(6):2818-23. PubMed ID: 7189536
    [No Abstract]   [Full Text] [Related]  

  • 12. Lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by acid-activated serum.
    Hänsch G; Hammer C; Jiji R; Rother U; Shin M
    Immunobiology; 1983 Mar; 164(2):118-26. PubMed ID: 6852860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical applications of complement assays.
    Alper CA; Rosen FS
    Adv Intern Med; 1975; 20():61-88. PubMed ID: 46689
    [No Abstract]   [Full Text] [Related]  

  • 14. Mode of action of human C9: adsorption of multiple C9 molecules to cell-bound C8.
    Kolb WP; Müller-Eberhard HJ
    J Immunol; 1974 Aug; 113(2):479-88. PubMed ID: 4858623
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemolysis of sheep erythrocytes in guinea pig serum deficient in the fourth component of complement. II. Evidence for involvement of C1 and components of the alternate complement pathway.
    May JE; Frank MM
    J Immunol; 1973 Dec; 111(6):1668-76. PubMed ID: 4750863
    [No Abstract]   [Full Text] [Related]  

  • 16. Human glomerulonephritis and the C3 nephritic factor (C3NeF).
    Berthoux FC; Carpenter CB; Freyria AM; Traeger J; Merrill JP
    Clin Nephrol; 1976 Mar; 5(3):93-100. PubMed ID: 57022
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunobiology of complement.
    Burkholder PM; Littleton CE
    Pathobiol Annu; 1971; 1():215-39. PubMed ID: 4129958
    [No Abstract]   [Full Text] [Related]  

  • 18. Paroxysmal nocturnal hemoglobinuria, a clue disease.
    Hinz CF
    N Engl J Med; 1973 Oct; 289(14):744-5. PubMed ID: 4727533
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of human erythrocyte stromata on complement activation.
    Corrocher R; Tedesco F; Rabusin P; De Sandre G
    Br J Haematol; 1975 Feb; 29(2):235-41. PubMed ID: 33
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utilization of properdin in the alternate pathway of complement activation: isolation of properdin convertase.
    Stitzel AE; Spitzer RE
    J Immunol; 1974 Jan; 112(1):56-62. PubMed ID: 4130153
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.